Japan Rejects China’s ’New Militarism’ Criticism, Defense Minister Says
Japan’s defence minister Shinjiro Koizumi rebuffed China’s accusation that Tokyo is embracing a “new militarism” at the Shangri‑La Dialogue in Singapore. He highlighted Japan’s lack of nuclear weapons and strategic bombers while pointing to China’s own large arsenal. The remarks came as Japan eases weapons‑export rules, joins U.S.-led drills in the South China Sea, and deepens regional security ties. Koizumi warned of China’s growing “weaponisation of everything” and reaffirmed Japan’s commitment to a transparent defence posture.
Pentagon Chief Urges Allies to Boost Defence Spending Amid ’Alarm’ over China’s Buildup
U.S. Defence Secretary Pete Hegseth told Asian partners at the Shangri‑La Dialogue that they must raise defence spending to about 3.5% of GDP to counter China’s accelerating military buildup. He highlighted Washington’s own $1.5 trillion investment in modernising the U.S. force...
Social Media Companies to Pay $27 Million to Settle Kentucky School District’s Lawsuit, Records Show
A Kentucky school district secured roughly $27 million in settlements from Meta, Snap, TikTok, and YouTube over claims the platforms fuel a student mental‑health crisis. Meta paid the largest share at $9 million, while Snap and TikTok each contributed $8 million and YouTube...
Iran Could Open Strait of Hormuz Within a Month if Terms Agreed, State TV Says
State television in Tehran reported that Iran could restore shipping through the Strait of Hormuz to pre‑war levels within a month if a framework deal with the United States is reached, including a U.S. troop withdrawal. The United States dismissed...
Qorvo’s SWOT Analysis: Semiconductor Stock Navigates Merger Path
Qorvo Inc. is moving toward completion of its acquisition by Skyworks Solutions, a deal that values the combined RF semiconductor entity at roughly $22 billion. The transaction offers $32.50 in cash plus 0.960 Skyworks shares per Qorvo share and is expected...
Kura Oncology’s SWOT Analysis: Biotech Stock Faces Launch Test
Kura Oncology secured FDA approval in November 2025 for Komzifti (ziftomenib) to treat relapsed or refractory NPM1‑mutated acute myeloid leukemia, propelling its stock nearly 100% higher over the past year. However, Q4 2025 sales fell short of analyst expectations, highlighting early‑launch...
Ionis Pharmaceuticals’ SWOT Analysis: Stock Gains Momentum on FDA Approval
Ionis Pharmaceuticals (NASDAQ:IONS) secured FDA approval for REDEMPLO, the first siRNA therapy targeting familial chylomicronemia syndrome (FCS), in November 2025. The drug’s clean label, quarterly at‑home dosing and broad indication have positioned it for rapid uptake, with payer agreements covering...
BOJ’s Ueda Meets PM Takaichi, Discusses Monetary Policy Stance
Bank of Japan Governor Kazuo Ueda met Prime Minister Sanae Takaichi to review the BOJ's monetary‑policy stance. Ueda declined to comment on market speculation about a possible June rate hike, emphasizing no specific discussion on that topic. Both leaders reaffirmed...
Australia Jobless Rate Hits Highest Since 2021 in April
Australia’s unemployment rate climbed to 4.5% in April, the highest level since 2021, as the labour market showed its first signs of cooling. The Australian Bureau of Statistics reported a loss of 18,600 jobs, reversing March’s 17,900‑job gain, while full‑time...
Analysis-Bond Yield Spike Is Risk to Unprepared Equities Market, Investors Warn
Investors warn that a sudden rise in U.S. Treasury yields—30‑year rates above 5% and 10‑year yields over 4.5%—poses a hidden threat to an equity market buoyed by strong first‑quarter earnings and AI‑driven growth. The S&P 500 has rallied more than 8%...
Allegiant Completes Acquisition of Sun Country Airlines, Triggers Nasdaq Delisting
Allegiant Travel Company completed its acquisition of Sun Country Airlines, making the carrier a wholly‑owned subsidiary. Sun Country shareholders received $4.10 in cash and 0.1557 Allegiant shares per share, valuing the airline at roughly $876 million. The transaction triggered the suspension...
Stifel Initiates Alamar Biosciences Stock with Buy Rating
Stifel initiated coverage of Alamar Biosciences (NASDAQ: ALMR) with a buy rating and a $28 price target, citing the ARGO platform’s best‑in‑class multiplex proteomics capabilities. The company posted roughly 200% revenue growth last year, reaching $74.21 million and a $1.63 billion market...
KBC Q1 Profit Misses Expectations on Geopolitical Reserve Build
KBC Group posted Q1 2026 net profit of €557 million (≈$600 million), falling short of the €578 million consensus. The miss stemmed from €165 million in impairment charges, including a €75 million boost to its geopolitical and macro‑economic expected credit loss reserve, now €175 million. Net...
Bitcoin Steadies at $81k with Iran Tensions, US CPI in Focus
Bitcoin hovered around $81,300 on Tuesday, trading in a narrow band as hopes for a U.S.–Iran peace deal faded. The cryptocurrency rose 0.5% after briefly touching $82,000 over the weekend. Market participants also braced for the U.S. Consumer Price Index...
Trump and China’s Xi Set for Talks Spanning Iran, Nuclear, Trade and AI
U.S. President Donald Trump is traveling to Beijing for his first visit since 2017, where he will meet Chinese President Xi Jinping for two days of high‑level talks. The agenda spans Iran’s war, Taiwan tensions, artificial‑intelligence risks, and nuclear weapons,...